Previous close | 4.6200 |
Open | 4.6300 |
Bid | 4.3000 x 1400 |
Ask | 4.4700 x 3200 |
Day's range | 4.3850 - 4.6300 |
52-week range | 2.5200 - 12.8900 |
Volume | |
Avg. volume | 2,611,362 |
Market cap | 1.322B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.7960 |
Earnings date | 09 Aug 2022 - 15 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.95 |
The catalyst that sent the telehealth software company higher was bullish commentary courtesy of a Wall Street analyst. Piper Sandler analyst Sean Wieland raised his price target on American Well (also called Amwell) to $6, up from its previous level of $5. The analyst cited numerous client wins, including the recent signing of CVS Health (NYSE: CVS), which he sees as "marquee reference customers."
Among the hottest stocks last month was Amwell (NYSE: AMWL). It was shortly after the company reported earnings last month that Amwell's stock started to gain momentum. For the first three months of 2022, Amwell posted sales of $64.2 million which rose 12% year over year.
BOSTON, June 08, 2022--Amwell appoints Dr. Carrie Nelson to the role of Chief Medical Officer.